For Health Systems
Expand research capacity without expanding overhead.
Clinical trials come in waves. We are here to smooth the water. Whether you are standing up a research program from nothing, absorbing more studies than your team can staff, or trying to make an existing program financially defensible, our support is scoped to the gap rather than sold as a package.
- Engagement
- Scoped to the gap
- Model
- Embedded or fully delegated
- Network
- De novo site development
- Oversight
- Centralized and auditable
The structural argument
Scale is an advantage everywhere except trial startup.
Large institutions carry high overhead, layered approval processes, and startup timelines that sponsors have learned to price in. Smaller community and regional sites often start faster and recruit better, particularly in suburban and rural populations, which is why budget-conscious sponsors increasingly route studies to networks rather than to flagship academic centres.
That does not mean a health system should cede the work. It means the operating layer has to change. What a system needs is standardized startup, centralized feasibility, honest coverage analysis, and someone accountable for the portfolio view — the same infrastructure a purpose-built SMO already runs.
We supply that layer. Sometimes that means building a research program inside your system from scratch. Sometimes it means taking overflow studies off a team that is already at capacity. Sometimes it is a single coverage analysis. We would rather scope it honestly than oversell it.
Service lines
Where systems typically bring us in.
Coverage analysis
Item-by-item determination of what is billable to a payer versus what the study must fund, documented to withstand audit and protect against improper billing exposure.
Cohort and study matching
Your patient population assessed against available protocols so the studies you take on are the ones you can actually enroll.
Site network development
Standing up new research sites across your footprint, including de novo sites in communities with no prior research infrastructure.
SMO support
Our operating layer applied to your existing sites: centralized feasibility, templated startup, standardized training, and portfolio reporting.
Study and protocol design
Design consultation informed by what actually executes at the site level, including where decentralized elements will reduce burden without weakening the endpoint.
Regulatory compliance
IRB strategy, essential document management, delegation and training records, deviation handling, and inspection readiness.
Data management
eSource capture, eISF and eReg document control, query resolution, and centralized monitoring against pre-specified tolerance limits.
Training and education
GCP certification, protocol-specific training, and investigator development for clinicians new to research.
Specialized and custom consulting
Program assessment, financial modelling, and remediation for research operations that are underperforming or losing money.
Typical starting points
Engagements usually begin with one of these.
- A research program that leadership wants started but nobody has capacity to build
- More awarded studies than coordinators to run them
- A program that is enrolling well but not covering its own costs
- Coverage analysis exposure that has never been formally reviewed
- Sponsors declining your sites on startup-timeline grounds
- Community or rural clinics in your footprint that could become sites
- Long-horizon registry or post-market commitments with no staffing plan
- An upcoming inspection and an oversight trail that is thinner than it should be
Also relevant
Other ways we work.
Our remote clinical nursing team supports every one of these relationships. See remote and decentralized monitoring.
Start a conversation
Tell us what is not working. We will tell you what we would do about it.
A short discovery conversation is usually enough to establish whether the gap is capacity, infrastructure, economics, or all three.